Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Dobrocky

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Journal of Chromatography|January 14, 1994
Rapid method for the routine determination of caffeine and its metabolites by high-performance liquid chromatographyP Dobrocky, P N Bennett, L J Notarianni
British Journal of Clinical Pharmacology|March 1, 1996
Caffeine as a metabolic probe: NAT2 phenotypingL J Notarianni, P Dobrocky, G Godlewski, et al.
British Journal of Clinical Pharmacology|January 1, 1995
Caffeine as a metabolic probe: a comparison of the metabolic ratios used to assess CYP1A2 activityL J Notarianni, S E Oliver, P Dobrocky, et al.
Gut|February 1, 1995
Caffeine phenotyping of cytochrome P4501A2, N-acetyltransferase, and xanthine oxidase in patients with familial adenomatous polyposisA D Spigelman, K C Farmer, S Oliver, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Journal of Chromatography|January 14, 1994
Rapid method for the routine determination of caffeine and its metabolites by high-performance liquid chromatographyP Dobrocky, P N Bennett, L J Notarianni
British Journal of Clinical Pharmacology|March 1, 1996
Caffeine as a metabolic probe: NAT2 phenotypingL J Notarianni, P Dobrocky, G Godlewski, et al.
British Journal of Clinical Pharmacology|January 1, 1995
Caffeine as a metabolic probe: a comparison of the metabolic ratios used to assess CYP1A2 activityL J Notarianni, S E Oliver, P Dobrocky, et al.
Gut|February 1, 1995
Caffeine phenotyping of cytochrome P4501A2, N-acetyltransferase, and xanthine oxidase in patients with familial adenomatous polyposisA D Spigelman, K C Farmer, S Oliver, et al.
Pageof 1